Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-25-221028

Chief Legal Officer sold 2,407 shares at $8.00 ($19,256)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Bizily Scott · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-23 Sale : show line 1 in the form 10b5-1 −2,407 $8.00 $19,256 7,596 D
Open-market sales · 2,407 sh · avg $8.00 · $19,256
Loading xslF345X05/ownership.xml…